Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2011-01-21 Proxy Solicitation & In…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
TERMINATION OF EXISTING SHARE OPTION SCHEME AND ADOPTION OF NEW SHARE OPTION SCHEME
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a circular addressed to shareholders regarding the termination of an existing share option scheme and the adoption of a new share option scheme. It includes a notice convening an extraordinary general meeting (EGM) for shareholders to approve these changes. The content focuses on corporate governance matters related to share option schemes, including detailed terms and conditions, definitions, and procedural information for the EGM. There is no financial data, earnings information, or audit content. The document is not a report itself but a solicitation and information statement to shareholders to vote on corporate governance matters. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2011-01-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2010
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2010, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document is lengthy (over 13,000 characters) and contains detailed data, not just an announcement or certification. This type of document fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2011-01-05 English
CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding multiple continuing connected transactions entered into on 31 December 2010. It details agreements with related parties (connected persons) under the Listing Rules, including descriptions of the transactions, parties involved, annual caps, and reasons for the transactions. The document is structured as a formal announcement with detailed disclosures about connected transactions, which is typical for regulatory announcements related to ongoing business dealings with related parties. It does not contain financial statements, earnings data, or management discussion of financial results. It is not a full annual or interim report, nor is it a call transcript or audit report. It is not a proxy solicitation or voting results announcement. The content fits the category of a regulatory announcement about continuing connected transactions under stock exchange rules, which is best classified as a Regulatory Filing (RNS). The document length (15,000 characters) and detailed content confirm it is not a brief report publication announcement or a short certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2010-12-31 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2010
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2010, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement. The document length is over 13,000 characters, indicating it is a full report rather than a brief announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about share capital movements that does not fit into more specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS), since it covers a broad range of share capital movements and is a monthly return report to the exchange.
2010-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2010
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2010, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. The document is not an annual or interim report, earnings release, or management discussion. It is a regulatory announcement about share capital changes, fitting best under Regulatory Filings (RNS).
2010-11-03 English
RESIGNATION OF EXECUTIVE DIRECTOR APPOINTMENT OF EXECUTIVE DIRECTOR CHANGE OF CHAIRMAN AND CHANGE OF AUTHORIZED REPRESENTATIVE
Board/Management Information Classification · 100% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding the resignation and appointment of executive directors, a change of chairman, and a change of authorized representative. It details personnel changes at the board and senior management level, including biographical information about the new appointee and confirmations from the resigning director. There is no financial data, no mention of financial results, no audit information, and no regulatory filings about financial performance. The content focuses solely on changes in the company's board and senior management positions. Therefore, this document fits the category of Board/Management Information (MANG). The document length (7590 characters) supports it being a full announcement rather than a brief notice or a report publication announcement.
2010-10-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.